DART Study: A phase 2 randomized trial of dalantercept plus axitinib versus placebo plus axitinib in advanced renal cell carcinoma (RCC): Results from the part 1 dose escalation cohorts Meeting Abstract
| Authors: | Voss, M. H.; Plimack, E.; Rini, B.; Atkins, M. B.; Alter, R.; Beck, J. T.; Bhatt, R. S.; Pappas, K.; Wilson, D.; Sherman, M. L.; Pandya, S. |
| Abstract Title: | DART Study: A phase 2 randomized trial of dalantercept plus axitinib versus placebo plus axitinib in advanced renal cell carcinoma (RCC): Results from the part 1 dose escalation cohorts |
| Meeting Title: | 13th International Kidney Cancer Symposium |
| Journal Title: | BJU International |
| Volume: | 114 |
| Issue: | Suppl. S4 |
| Meeting Dates: | 2014 OCT 24-25 |
| Meeting Location: | Chicago, IL |
| ISSN: | 1464-4096 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2014-10-01 |
| Start Page: | 16 |
| End Page: | 17 |
| Language: | English |
| ACCESSION: | WOS:000344393900031 |
| PROVIDER: | wos |
| DOI: | 10.1111/bju.12941 |
| Notes: | Meeting Abstract -- 13th International Kidney Cancer Symposium -- OCT 24-25, 2014 -- Chicago, IL -- 4 -- SI -- Source: Wos |
